This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
2.P Godoy , Measles epidemiology in Catalonia (Spain): implications for a regional vaccination programme. International Journal of Epidemiology 1999; 28: 558–562.
6.MS Lee , Seroepidemiology and evaluation of passive surveillance during 1988–1989 measles outbreak in Taiwan. International Journal of Epidemiology 1992; 21: 1165–1174.
8.WY Cheng , Molecular evolution of measles viruses circulated in Taiwan 1992–2008. Virology Journal 2009; 6: 219.
12.GM Mendelson , Nosocomial transmission of measles to healthcare workers. Time for a national screening and immunization policy for NHS staff? Journal of Hospital Infection 2000; 44: 154–155.
14.WL Atkinson , Transmission of measles in medical settings – United States, 1985–1989. American Journal of Medicine 1991; 91: 320S–324S.
15.RM Davis , Transmission of measles in medical settings: 1980 through 1984. Journal of American Medical Association 1986; 255: 1295–1298.
20.MS Lee , Measles seroepidemiology and decay rate of vaccine-induced measles IgG titers in Taiwan, 1995–1997. Vaccine 2001; 19: 4644–4651.
21.LC McDonald , SARS in healthcare facilities, Toronto and Taiwan. Emerging Infectious Diseases 2004; 10: 777–781.
22.SS Yalcin , G Kanra , T Pehlivan . Outbreak of measles in medical students and determination of immune status to measles-mumps-rubella viruses. International Journal of Adolescent Medicine and Health 2006; 18: 615–622.
23.S Wicker , Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Medical Microbiology and Immunology 2007; 196: 145–150.
24.CJ Williams , Low measles, mumps and rubella (MMR) vaccine uptake in hospital healthcare worker contacts following suspected mumps infection. Journal of Hospital Infection 2010; 76: 91–92.
25.A Tischer , E Gerike . Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella. Vaccine 2000; 18: 1382–1392.
27.IJ Amanna , NE Carlson , MK Slifka . Duration of humoral immunity to common viral and vaccine antigens. New England Journal of Medicine 2007; 357: 1903–1915.
28.MS Dine , Persistence of vaccine-induced antibody to measles 26–33 years after vaccination. Journal of Infectious Diseases 2004; 189: S123–S130.
29.I Davidkin , Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. Journal of Infectious Diseases 2008; 197: 950–956.
31.U Fedeli , C Zanetti , B Saia . Susceptibility of healthcare workers to measles, mumps, rubella and varicella. Journal of Hospital Infection 2002; 51: 133–135.
32.MA Almuneef , Seroprevalence survey of varicella, measles, rubella, and hepatitis A and B viruses in a multinational healthcare workforce in Saudi Arabia. Infection Control and Hospital Epidemiology 2006; 27: 1178–1183.